Literature DB >> 9872631

Alveolar macrophage and glycoprotein responses to Pneumocystis carinii.

A H Limper1.   

Abstract

Pneumocystis carinii continues to represent an important complication of immunosuppression in patients with acquired immune deficiency syndrome, hematological and solid malignancies, organ transplantation, and during corticosteroid and cytotoxic therapy for inflammatory disorders. Although host defenses against this organism center around CD4 lymphocytic function, additional immune mediators in the alveolar spaces contribute substantially to host recognition and elimination of P. carinii. In particular, this review considers the interactions of P. carinii with alveolar macrophages, adhesive glycoproteins including vitronectin and fibronectin, and surfactant lipids and protein components. Recent studies indicate that alveolar macrophages contribute significantly to host responses against this organism by mediating uptake and degradation of P. carinii, and by releasing inflammatory mediators including reactive oxidants, eicosanoids, and the potent proinflammatory cytokine tumor necrosis factor-alpha. Furthermore, the interactions of P. carinii with multiple adhesive proteins and with surfactant components additionally modulate the interactions of P. carinii with macrophages and enhance host recognition of this pathogen. These non-lymphocytic mediators represent additional important mechanisms of host recognition and response to P. carinii infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872631

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  8 in total

1.  Chitinases in Pneumocystis carinii pneumonia.

Authors:  Leah R Villegas; Theodore J Kottom; Andrew H Limper
Journal:  Med Microbiol Immunol       Date:  2012-04-26       Impact factor: 3.402

2.  Lung compartmentalization of inflammatory cells in sepsis.

Authors:  K Yin; J Wilmanski; C Wang; G Qiu; M Tahamont
Journal:  Inflammation       Date:  2000-12       Impact factor: 4.092

3.  Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.

Authors:  Steve D Swain; Terry W Wright; Peter M Degel; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.

Authors:  Mark E Lasbury; Xing Tang; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

5.  Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo.

Authors:  Steve D Swain; Sena J Lee; Michel C Nussenzweig; Allen G Harmsen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages.

Authors:  Suk-Joong Yong; Zvezdana Vuk-Pavlovic; Joseph E Standing; Erika C Crouch; Andrew H Limper
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

7.  Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages.

Authors:  Mark E Lasbury; Peimao Lin; Dennis Tschang; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

8.  Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer.

Authors:  Eun Hye Lee; Eun Young Kim; Sang Hoon Lee; Yun Ho Roh; Ah Young Leem; Joo Han Song; Song Yee Kim; Kyung Soo Chung; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Joon Chang; Moo Suk Park
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.